Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:chemicalClass |
triazolopyrimidine derivative
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Lupin_Limited
|
| https://www.w3.org/2000/01/rdf-schema#label |
LFT 1135
|
| gptkbp:mechanismOfAction |
inhibits Plasmodium falciparum dihydroorotate dehydrogenase
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:Plasmodium_falciparum
|
| gptkbp:usedFor |
malaria
|
| gptkbp:bfsParent |
gptkb:Ross_128
|
| gptkbp:bfsLayer |
7
|